Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes

Virus Research

Volumn 119, Issue 2, 2006, Pages 134-145

  Savard, Martin ^a   Gosselin, Jean ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Epstein Barr virus; Innate response; Monocyte; Neutrophil; Suppression

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 6; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; HUMAN; IMMUNE DEFICIENCY; INNATE IMMUNITY; MONOCYTE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, NATURAL; MONOCYTES; NEUTROPHILS; PHAGOCYTES;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 33646764238     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.02.008     Document Type: Review

References (131)

1. Arend W.P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88 (1991) 1445-1451
2. Babcock G.J., Hochberg D., and Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13 (2000) 497-506
3. Baggiolini M., Dewald B., and Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55 (1994) 97-179
4. Baumann M., Gires O., Kolch W., Mischak H., Zeidler R., Pich D., and Hammerschmidt W. The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1. Eur. J. Biochem. 267 (2000) 3891-3901
5. Beaulieu A.D., Paquin R., and Gosselin J. Epstein-Barr virus modulates de novo protein synthesis in human neutrophils. Blood 86 (1995) 2789-2798
6. Bose S., Kar N., Maitra R., DiDonato J.A., and Banerjee A.K. Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10890-10895
7. Callan M.F. The immune response to Epstein-Barr virus. Microbes Infect. 6 (2004) 937-945
8. Cassatella M.A. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16 (1995) 21-26
9. Cayrol C., and Flemington E.K. Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. J. Virol. 69 (1995) 4206-4212
10. Cayrol C., and Flemington E.K. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15 (1996) 2748-2759
11. Chi T., and Carey M. Assembly of the isomerized TFIIA-TFIID-TATA ternary complex is necessary and sufficient for gene activation. Genes Dev. 10 (1996) 2540-2550
12. Daigneault D.E., Hartshorn K.L., Liou L.S., Abbruzzi G.M., White M.R., Oh S.K., and Tauber A.I. Influenza A virus binding to human neutrophils and cross-linking requirements for activation. Blood 80 (1992) 3227-3234
13. Decker T., Lohmann-Matthes M.L., and Gifford G.E. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138 (1987) 957-962
14. Delsol G., Meggetto F., Brousset P., Cohen-Knafo E., al Saati T., Rochaix P., Gorguet B., Rubin B., Voigt J.J., and Chittal S. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am. J. Pathol. 142 (1993) 1729-1738
15. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 77 (1991) 1627-1652
16. Dinarello C.A., and Thompson R.C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12 (1991) 404-410
17. Douglas Jr. R.G., Alford R.H., Cate T.R., and Couch R.B. The leukocyte response during viral respiratory illness in man. Ann. Intern. Med. 64 (1966) 521-530
18. Eriksson K.F., Holmberg L., and Bergstrand C.G. Infectious mononucleosis and agranulocytosis. Scand. J. Infect. Dis. 11 (1979) 307-309
19. Faden H., Hong J.J., and Ogra P.L. Interaction of polymorphonuclear leukocytes and viruses in humans: adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells. J. Virol. 52 (1984) 16-23
20. Fedyk E.R., Brown D.M., and Phipps R.P. PGE2 regulation of B lymphocytes and T helper 1 and T helper 2 cells: induction of inflammatory versus allergic responses. Adv. Exp. Med. Biol. 407 (1997) 237-242
21. Feinman R., Henriksen-DeStefano D., Tsujimoto M., and Vilcek J. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J. Immunol. 138 (1987) 635-640
22. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., and Fearon D.T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4510-4514
23. Flamand L., Borgeat P., Lalonde R., and Gosselin J. Release of anti-HIV mediators after administration of leukotriene B4 to humans. J. Infect. Dis. 189 (2004) 2001-2009
24. Foss H.D., Herbst H., Hummel M., Araujo I., Latza U., Rancso C., Dallenbach F., and Stein H. Patterns of cytokine gene expression in infectious mononucleosis. Blood 83 (1994) 707-712
25. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
26. Gagnon L., Girard M., Sullivan A.K., and Rola-Pleszczynski M. Augmentation of human natural cytotoxic cell activity by leukotriene B4 mediated by enhanced effector-target cell binding and increased lytic efficiency. Cell. Immunol. 110 (1987) 243-252
27. Giulian D., Vaca K., and Noonan C.A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250 (1990) 1593-1596
28. Gosselin J., and Borgeat P. Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells. Blood 89 (1997) 2122-2130
29. Gosselin J., Borgeat P., and Flamand L. Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation. J. Immunol. 174 (2005) 1587-1593
30. Gosselin J., Flamand L., D'Addario M., Hiscott J., and Menezes J. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha. J. Clin. Invest. 89 (1992) 1849-1856
31. Gosselin J., Flamand L., D'Addario M., Hiscott J., Stefanescu I., Ablashi D.V., Gallo R.C., and Menezes J. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J. Immunol. 149 (1992) 181-187
32. Gosselin J., Menezes J., D'Addario M., Hiscott J., Flamand L., Lamoureux G., and Oth D. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur. J. Immunol. 21 (1991) 203-208
33. Gosselin J., Savard M., Tardif M., Flamand L., and Borgeat P. Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4. Clin. Exp. Immunol. 126 (2001) 494-502
34. Granja A.G., Nogal M.L., Hurtado C., Vila V., Carrascosa A.L., Salas M.L., Fresno M., and Revilla Y. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. J. Biol. Chem. 279 (2004) 53736-53746
35. Guerreiro-Cacais A.O., Li L., Donati D., Bejarano M.T., Morgan A., Masucci M.G., Hutt-Fletcher L., and Levitsky V. Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J. Gen. Virol. 85 (2004) 2767-2778
36. Habib M.A., Babka J.C., and Burningham R.A. Profound granulocytopenia associated with infectious mononucleosis. Am. J. Med. Sci. 265 (1973) 339-346
37. Hahn A.M., Huye L.E., Ning S., Webster-Cyriaque J., and Pagano J.S. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 79 (2005) 10040-10052
38. Hammond W.P., Harlan J.M., and Steinberg S.E. Severe neutropenia in infectious mononucleosis. West. J. Med. 131 (1979) 92-97
39. Hannum C.H., Wilcox C.J., Arend W.P., Joslin F.G., Dripps D.J., Heimdal P.L., Armes L.G., Sommer A., Eisenberg S.P., and Thompson R.C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343 (1990) 336-340
40. Hartshorn K.L., Liou L.S., White M.R., Kazhdan M.M., Tauber J.L., and Tauber A.I. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J. Immunol. 154 (1995) 3952-3960
41. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., and Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8479-8483
42. Hirano T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16 (1998) 249-284
43. Hornef M.W., Wagner H.J., Kruse A., and Kirchner H. Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo. Clin. Diagn. Lab. Immunol. 2 (1995) 209-213
44. Hyman A., Yim C., Krajden M., Read S., Basinski A.S., Wanless I., Levy G., and Heathcote J. Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C. J. Viral. Hepat. 6 (1999) 329-336
45. Jabs W.J., Wagner H.J., Maurmann S., Hennig H., and Kreft B. Inhibition of macrophage inflammatory protein-1 alpha production by Epstein-Barr virus. Blood 99 (2002) 1512-1516
46. Janssen O., and Kabelitz D. Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus. J. Immunol. 140 (1988) 125-130
47. Jhaveri R., Kundu P., Shapiro A.M., Venkatesan A., and Dasgupta A. Effect of heptitis C virus core protein on cellular gene expression: specific inhibition of cyclooxygenase 2. J. Infect. Dis. 191 (2005) 1498-1506
48. Kawa K. Epstein-Barr virus-associated diseases in humans. Int. J. Hematol. 71 (2000) 108-117
49. Kawanishi M. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J. Virol. 71 (1997) 3319-3322
50. Kehrl J.H., Miller A., and Fauci A.S. Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J. Exp. Med. 166 (1987) 786-791
51. Kent S.J., Stent G., Sonza S., Hunter S.D., and Crowe S.M. HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression. Clin. Exp. Immunol. 95 (1994) 450-454
52. Keranen L.M., Dutil E.M., and Newton A.C. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr. Biol. 5 (1995) 1394-1403
53. Kobayashi N., Boyer T.G., and Berk A.J. A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly. Mol. Cell. Biol. 15 (1995) 6465-6473
54. Koide J., Takada K., Sugiura M., Sekine H., Ito T., Saito K., Mori S., Takeuchi T., Uchida S., and Abe T. Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J. Virol. 71 (1997) 2478-2481
55. Korchak H.M., and Kilpatrick L.E. Roles for beta II-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL60 cells. J. Biol. Chem. 276 (2001) 8910-8917
56. Larochelle B., Flamand L., Gourde P., Beauchamp D., and Gosselin J. Epstein-Barr virus infects and induces apoptosis in human neutrophils. Blood 92 (1998) 291-299
57. Li L., Liu D., Hutt-Fletcher L., Morgan A., Masucci M.G., and Levitsky V. Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 99 (2002) 3725-3734
58. Li Q., Spriggs M.K., Kovats S., Turk S.M., Comeau M.R., Nepom B., and Hutt-Fletcher L.M. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71 (1997) 4657-4662
59. Lieberman P.M., and Berk A.J. The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev. 5 (1991) 2441-2454
60. Lieberman P.M., Ozer J., and Gursel D.B. Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition. Mol. Cell. Biol. 17 (1997) 6624-6632
61. Linde A., Andersson B., Svenson S.B., Ahrne H., Carlsson M., Forsberg P., Hugo H., Karstorp A., Lenkei R., Lindwall A., et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J. Infect. Dis. 165 (1992) 994-1000
62. + T lymphocytes. FASEB J. 8 (1994) 1055-1060
63. Lotz M., Tsoukas C.D., Fong S., Dinarello C.A., Carson D.A., and Vaughan J.H. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. J. Immunol. 136 (1986) 3636-3642
64. Macsween K.F., and Crawford D.H. Epstein-Barr virus-recent advances. Lancet Infect. Dis. 3 (2003) 131-140
65. Mahot S., Sergeant A., Drouet E., and Gruffat H. A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J. Gen. Virol. 84 (2003) 965-974
66. Marcinkiewicz J., and Chain B.M. Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP. Cell. Immunol. 149 (1993) 303-314
67. McColl S.R., Roberge C.J., Larochelle B., and Gosselin J. EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils. J. Immunol. 159 (1997) 6164-6168
68. Mellor H., and Parker P.J. The extended protein kinase C superfamily. Biochem. J. 332 Pt 2 (1998) 281-292
69. Mestan J., Digel W., Mittnacht S., Hillen H., Blohm D., Moller A., Jacobsen H., and Kirchner H. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323 (1986) 816-819
70. Miyashita E.M., Yang B., Babcock G.J., and Thorley-Lawson D.A. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71 (1997) 4882-4891
71. Mochly-Rosen D., and Gordon A.S. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J. 12 (1998) 35-42
72. Mochly-Rosen D., Khaner H., and Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3997-4000
73. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., and Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11 (1993) 165-190
74. Moore K.W., Vieira P., Fiorentino D.F., Trounstine M.L., Khan T.A., and Mosmann T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248 (1990) 1230-1234
75. Morrison T.E., Mauser A., Klingelhutz A., and Kenney S.C. Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J. Virol. 78 (2004) 544-549
76. Morrison T.E., Mauser A., Wong A., Ting J.P., and Kenney S.C. Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein. Immunity 15 (2001) 787-799
77. Neel E.U. Infectious mononucleosis. Death due to agranulocytosis and pneumonia. JAMA 236 (1976) 1493-1494
78. Nottet H.S., Jett M., Flanagan C.R., Zhai Q.H., Persidsky Y., Rizzino A., Bernton E.W., Genis P., Baldwin T., Schwartz J., et al. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154 (1995) 3567-3581
79. Ongràdi J., and Telekes A. Relationship between the prostaglandin cascade and virus infection. Acta Virol. 34 (1990) 380-400
80. Ongràdi J., Telekes A., Farfas J., Nasz I., and Bendinelli M. The effect of prostaglandins on the replication of adenovirus wild types and temperature-sensitive mutants. Acta Microbiol. Immunol. Hung. 41 (1994) 173-188
81. Ortaldo J.R., Mason L.H., Mathieson B.J., Liang S.M., Flick D.A., and Herberman R.B. Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature 321 (1986) 700-702
82. Paul C.C., and Baumann M.A. Modulation of spontaneous outgrowth of Epstein-Barr virus immortalized B-cell clones by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 75 (1990) 54-58
83. Peters-Golden M., Canetti C., Mancuso P., and Coffey M.J. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174 (2005) 589-594
84. Price P., Winter J.G., Nikoletti S., Hudson J.B., and Shellam G.R. Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection. J. Virol. 61 (1987) 3602-3606
85. Qu L., and Rowe D.T. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66 (1992) 3715-3724
86. Ratcliffe D.R., Nolin S.L., and Cramer E.B. Neutrophil interaction with influenza-infected epithelial cells. Blood 72 (1988) 142-149
87. Revoltella R.P., Vigneti E., Fruscalzo A., Park M., Ragona G., Rocchi G., and Calef E. Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis. J. Gen. Virol. 70 Pt 5 (1989) 1203-1215
88. Rickinson A.B., and Moss D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15 (1997) 405-431
89. Roberge C.J., Larochelle B., Rola-Pleszczynski M., and Gosselin J. Epstein-Barr virus induces GM-CSF synthesis by monocytes: effect on EBV-induced IL-1 and IL-1 receptor antagonist production in neutrophils. Virology 238 (1997) 344-352
90. Roberge C.J., McColl S.R., Larochelle B., and Gosselin J. Granulocyte-macrophage colony-stimulating factor enhances EBV-induced synthesis of chemotactic factors in human neutrophils. J. Immunol. 160 (1998) 2442-2448
91. Roberge C.J., Poubelle P.E., Beaulieu A.D., Heitz D., and Gosselin J. The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrophils to EBV stimulation. Preponderance of IL-Ra detection. J. Immunol. 156 (1996) 4884-4891
92. Rocha P.N., Plumb T.J., and Coffman T.M. Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin. Immunopathol. 25 (2003) 215-227
93. Rochford R., Cannon M.J., Sabbe R.E., Adusumilli K., Picchio G., Glynn J.M., Noonan D.J., Mosier D.E., and Hobbs M.V. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 10 (1997) 183-195
94. Rodriguez A., Armstrong M., Dwyer D., and Flemington E. Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product. Zta. J. Virol. 73 (1999) 9029-9038
95. Rodriguez A., Jung E.J., Yin Q., Cayrol C., and Flemington E.K. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284 (2001) 159-169
96. Rola-Pleszczynski M., Gagnon L., and Sirois P. Leukotriene B4 augments human natural cytotoxic cell activity. Biochem. Biophys. Res. Commun. 113 (1983) 531-537
97. Roncella S., Baldi L., Cutrona G., Viale M., Rizzo F., Gasco M., Ferrarini M., and Pistoia V. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection. Clin. Immunol. Immunopathol. 77 (1995) 162-171
98. Sato T., Hirasawa A., Kawabuchi Y., Nishikawa T., and Wakabayashi Y. Cellular expressions and serum concentrations of Fas ligand and Fas receptor in patients with infectious mononucleosis. Int. J. Hematol. 72 (2000) 329-336
99. Savard M., Belanger C., Tardif M., Gourde P., Flamand L., and Gosselin J. Infection of primary human monocytes by Epstein-Barr virus. J. Virol. 74 (2000) 2612-2619
100. Savard M., Belanger C., Tremblay M.J., Dumais N., Flamand L., Borgeat P., and Gosselin J. EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J. Immunol. 164 (2000) 6467-6473
101. Schall T.J., Bacon K., Camp R.D., Kaspari J.W., and Goeddel D.V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177 (1993) 1821-1826
102. Schall T.J., and Bacon K.B. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6 (1994) 865-873
103. Schlitt A., Blankenberg S., Weise K., Gärtner B.C., Mehrer T., Peetz D., Meyer J., Darius H., and Rupprecht H.J. Herpesvirus DNA (Epstein-Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease. Acta Cardiol. 60 (2005) 605-610
104. Schooley R.T., Densen P., Harmon D., Felsenstein D., Hirsch M.S., Henle W., and Weitzman S. Antineutrophil antibodies in infectious mononucleosis. Am. J. Med. 76 (1984) 85-90
105. Setsuda J., Teruya-Feldstein J., Harris N.L., Ferry J.A., Sorbara L., Gupta G., Jaffe E.S., and Tosato G. Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphpoproliferative disease. Am. J. Pathol. 155 (1999) 257-265
106. Shalaby M.R., Espevik T., Rice G.C., Ammann A.J., Figari I.S., Ranges G.E., and Palladino Jr. M.A. The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction. J. Immunol. 141 (1988) 499-503
107. Shimakage M., Kimura M., Yanoma S., Ibe M., Yokota S., Tsujino G., Kozuka T., Dezawa T., Tamura S., Ohshima A., Yutsudo M., and Hakura A. Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch. Virol. 144 (1999) 157-166
108. Sinclair A.J. bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 84 (2003) 1941-1949
109. Speck P., Haan K.M., and Longnecker R. Epstein-Barr virus entry into cells. Virology 277 (2000) 1-5
110. Speck S.H., Chatila T., and Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5 (1997) 399-405
111. Spender L.C., Cornish G.H., Rowland B., Kempkes B., and Farrell P.J. Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection. J. Virol. 75 (2001) 3537-3546
112. Spriggs M.K., Armitage R.J., Comeau M.R., Strockbine L., Farrah T., Macduff B., Ulrich D., Alderson M.R., Mullberg J., and Cohen J.I. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol. 70 (1996) 5557-5563
113. Stevens D.A., Ferrington R.A., Jordan G.W., and Merigan T.C. Cellular events in zoster vesicles: relation to clinical course and immune parameters. J. Infect. Dis. 131 (1975) 509-515
114. Stevens D.L., Everett E.D., Boxer L.A., and Landefeld R.A. Infectious mononucleosis with severe neutropenia and opsonic antineutrophil activity. South Med. J. 72 (1979) 519-521
115. Svedmyr E., Ernberg I., Seeley J., Weiland O., Masucci G., Tsukuda K., Szigeti R., Masucci M.G., Blomogren H., and Berthold W. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin. Immunol. Immunopathol. 30 (1984) 437-450
116. Tanaka J., Nomiyama H., Yamamoto T., Hamada F., and Kambara T. T-cell chemotactic activity of cytokine LD78: a comparative study with interleukin-8, a chemotactic factor for the T-cell CD45RA+ phenotype. Int. Arch. Allergy Immunol. 100 (1993) 201-208
117. Tardif M., Savard M., Flamand L., and Gosselin J. Impaired protein kinase C activation/translocation in Epstein-Barr virus-infected monocytes. J. Biol. Chem. 277 (2002) 24148-24154
118. Taylor-Wiedeman J., Sissons J.G., Borysiewicz L.K., and Sinclair J.H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72 Pt 9 (1991) 2059-2064
119. Thivierge M., Le Gouill C., Tremblay M.J., Stankovà J., and Rola-Pleszczynski M. Prostaglandin E2 induces resistance to human immunodefiency virus-1 infection in monocytes-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92 (1998) 40-45
120. Tilley S.L., Coffman T.M., and Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108 (2001) 15-23
121. Tosato G., Tanner J., Jones K.D., Revel M., and Pike S.E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 64 (1990) 3033-3041
122. Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., and Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur. J. Immunol. 25 (1995) 64-68
123. Underhill D.M., and Ozinsky A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20 (2002) 825-852
124. Van Strijp J.A., Van Kessel K.P., van der Tol M.E., Fluit A.C., Snippe H., and Verhoef J. Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch. Virol. 104 (1989) 287-298
125. Vandenabeele P., Jayaram B., Devos R., Shaw A., and Fiers W. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line. Eur. J. Immunol. 18 (1988) 1027-1031
126. Whittingham S., Naselli G., Harrison L.C., Boyd A.W., Cebon J., and Jack I. Cytokine production in response to Epstein-Barr virus infection of peripheral blood mononuclear cells in vitro. Immunol. Cell. Biol. 71 Pt 4 (1993) 259-264
127. Wong G.H., and Goeddel D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323 (1986) 819-822
128. Wright-Browne V., Schnee A.M., Jenkins M.A., Thall P.F., Aggarwal B.B., Talpaz M., and Estrov Z. Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence. Leuk. Lymphoma 30 (1998) 583-589
129. Wu F.Y., Chen H., Wang S.E., ApRhys C.M., Liao G., Fujimuro M., Farrell C.J., Huang J., Hayward S.D., and Hayward G.S. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 77 (2003) 1481-1500
130. Wulff H.R. Acute agranulocytosis following infectious mononucleosis. Report of a case. Scand. J. Haematol. 2 (1965) 179-182
131. Yokoi T., Miyawaki T., Yachie A., Kato K., Kasahara Y., and Taniguchi N. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 70 (1990) 100-105